Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Jan. 11, 2021, 11:42 a.m. EST

Biogen's stock is up 5% after Lilly reports positive data from an Alzheimer's study

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Biogen Inc. (BIIB)
  • X
    Eli Lilly & Co. (LLY)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Biogen Inc. /zigman2/quotes/201531540/composite BIIB +3.38% gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug Administration. Eli Lilly & Co. /zigman2/quotes/200106384/composite LLY +2.72% on Monday said its investigational drug, donanemab, slowed cognitive decline in patients with early forms of Alzheimer's in a mid-stage clinical study. The Lilly and Biogen drug candidates are in the same class of therapies. Both therapies focus on beta amyloid, which has been a somewhat controversial target for drug developers trying to figure out how best to treat people with Alzheimer's disease. The FDA is expected to decide whether to approve Biogen's drug, aducanumab, by March 7. "Though reported results are limited, today's topline is likely to reignite the bull debate on the amyloid hypothesis," RBC Capital Markets analyst Brian Abrahams told investors on Monday. "However, we believe key differences between donanemab and aducanumab and questions remain." Biogen's stock is down 9.8% over the last year. The S&P 500 /zigman2/quotes/210599714/realtime SPX +1.78% is up 17.5%.

/zigman2/quotes/201531540/composite
US : U.S.: Nasdaq
$ 272.47
+8.90 +3.38%
Volume: 547,032
March 5, 2021 2:58p
P/E Ratio
11.11
Dividend Yield
N/A
Market Cap
$40.15 billion
Rev. per Employee
$1.36M
loading...
/zigman2/quotes/200106384/composite
US : U.S.: NYSE
$ 206.00
+5.46 +2.72%
Volume: 2.26M
March 5, 2021 2:57p
P/E Ratio
30.30
Dividend Yield
1.65%
Market Cap
$192.20 billion
Rev. per Employee
$701,137
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,835.46
+66.99 +1.78%
Volume: 2.39B
March 5, 2021 2:58p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.